Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serlopitant versus placebo in adults with prurigo nodularis
2013-005024-42Phase 2Completed
- Sponsor
- Menlo Therapeutics
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in prurigo nodularis (PN) comparing Serlopitant 5 mg with Placebo (2 arms). Primary endpoints: Change in itch visual analog scale and Safety and tolerability. Started Apr 2014; status: completed.
02
Drugs
serlopitant
03
Conditions
prurigo nodularis (PN)
Beyond the preview
Go deeper on 2013-005024-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005024-42.